Statistics, ratios, and financial figures in this article are illustrative examples created for educational purposes. They may not reflect actual market conditions. Always verify data against authoritative sources.
Beyond individual stock signals, insider buying data can serve as a macro-level market indicator. The insider buy/sell ratio — the number of insider purchases divided by the number of insider sales across the entire market — is one of the most watched aggregate sentiment gauges among institutional investors.
Here's what the current data shows, how to interpret it, and where it breaks down.
Current reading: January 2026
The January 2026 buy/sell ratio of 0.35 means that for every 100 insider sales, there were 35 insider purchases. That's 40% above the 10-year average of 0.25.
How to interpret the ratio
The baseline asymmetry is important to understand: insiders sell far more often than they buy. This is structural, not bearish. Executives receive stock compensation (RSUs, options) as a significant portion of their pay, and selling some of it is normal portfolio diversification.
What matters is the deviation from baseline:
| Ratio | Reading | Historical context |
|---|---|---|
| > 0.40 | Strongly bullish | Seen near major market bottoms (Mar 2020, Oct 2022) |
| 0.30 – 0.40 | Bullish | Above average — insiders are accumulating |
| 0.20 – 0.30 | Neutral | Normal range — no aggregate signal |
| 0.15 – 0.20 | Cautious | Below average — insiders reducing exposure |
| < 0.15 | Bearish | Seen near market tops (early 2021, late 2024) |
Sector-level breakdown
The aggregate ratio masks significant sector variation. In January 2026:
Healthcare insiders are buying at 2x the overall average — consistent with the sector underperformance we've covered in previous analysis. Financials are also elevated, driven primarily by regional bank executives.
Meanwhile, tech and consumer discretionary are below average. Tech insiders are selling into the AI-driven rally rather than accumulating, which is worth noting even if it doesn't constitute a sell signal on its own.
Historical track record
The buy/sell ratio's value is primarily at extremes:
- March 2020: Ratio spiked to 0.68 during the pandemic crash. The S&P 500 bottomed within two weeks and returned 56% over the next 12 months.
- October 2022: Ratio hit 0.48 during the rate-hike selloff. The S&P 500 bottomed the same month and returned 26% over the following year.
- January 2021: Ratio dropped to 0.12 during the meme stock / SPAC euphoria. The Nasdaq peaked two months later and entered a prolonged bear market.
- November 2024: Ratio fell to 0.14. The market corrected 8% in the following quarter.
The pattern: insiders as a group are contrarian. They buy into fear and sell into euphoria. The ratio captures this behavior in aggregate.
Limitations
The buy/sell ratio is useful but not sufficient on its own:
- It's a lagging monthly metric. By the time a ratio is calculated and published, individual opportunities may have already moved. It's better as a backdrop than a timing tool.
- Sales are noisy. Insiders sell for many reasons unrelated to stock outlook — tax obligations, diversification mandates, real estate purchases, divorce settlements. A high sale count doesn't necessarily mean bearish conviction.
- Compensation structure matters. Companies that pay heavily in RSUs will naturally have higher insider selling. Comparing ratios across time periods with different compensation norms can mislead.
- It tells you nothing about individual stocks. A bullish aggregate ratio doesn't mean every stock with insider buying will outperform. Individual signal quality still matters.
We treat the buy/sell ratio as a context layer, not a primary signal. When the ratio is elevated (as it is now), we give slightly more weight to individual CEO purchase signals. When it's depressed, we apply tighter quality filters. It doesn't override our multi-factor scoring, but it informs how aggressively we interpret the results.
Current assessment
At 0.35, the January 2026 buy/sell ratio is in bullish territory. Insiders as a group are accumulating more aggressively than at any point since October 2022. The sector concentration in healthcare and financials is notable — these are the most under-owned sectors by institutional investors, and insiders are moving against the consensus positioning.
This doesn't mean the market goes up. It means the people with the most company-specific information are, in aggregate, more willing to deploy personal capital at current prices than they have been in over three years.